로딩 중…
지수 로딩 중…
Beta Bionics, Inc.
BBNX· NASDAQ· Health Care· Health Care Equipment & Services
$15.89-5.13%
2026-11-02
Financials
Valuation Metrics
Beta Bionics, Inc.'s Market Cap is $708M. At end of 2025 it was $1.23B. Ranked #2460 of 3,115 in US market (top 79%), #1010 of 1,472 on NASDAQ (top 69%), #160 of 203 in Health Care Equipment & Services (top 79%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $708M | US#2,460/3,115 Sec#160/203 |
| Revenue | $127M | US#2,645/3,115 Sec#179/203 |
| Net Income | $-83M | US—/3,115 Sec—/203 |
| Total Assets | $444M | US#2,909/3,115 Sec#177/203 |
| Net Assets | $401M | US#2,576/3,115 Sec#150/203 |
| Value | ||
| P/B | 1.76x | US#1,957/3,115 Sec#106/203 |
| P/S | 5.56x | US#2,580/3,115 Sec#170/203 |
| FCF Yield | -9.32% | US—/3,115 Sec—/203 |
| Profitability | ||
| ROE | -20.71% | US#2,552/3,115 Sec#156/203 |
| ROA | -18.73% | US#2,843/3,115 Sec#183/203 |
| Op. Margin | -72.75% | US#2,678/3,115 Sec#186/203 |
| Revenue Growth | 43.69% | US#214/3,115 Sec#9/203 |
| Financial Health | ||
| Debt Ratio | 10.56% | US#157/3,115 Sec#11/203 |
| Total Debt | $6M | US#2,872/3,115 Sec#193/203 |
| FCF | $-66M | US#2,552/3,115 Sec#183/203 |
| Cash | $82M | US#2,617/3,115 Sec#167/203 |
| Current Ratio | 8.92x | US#286/3,115 Sec#17/203 |
| Performance | ||
| 1Y Return | -41.62% | US#2,143/3,115 Sec#145/203 |
| 1M Return | -16.19% | US#2,015/3,115 Sec#163/203 |
| From 52W High | -51.42% | US#2,234/3,115 Sec#166/203 |
| 1Y MDD | -71.24% | US#2,947/3,115 Sec#190/203 |
| Trading | ||
| Volume | 654,760 shares | US#1,104/3,115 Sec#56/203 |
| Trading Value | $11M | US#1,593/3,115 Sec#109/203 |
| Per Share | ||
| EPS | $-1.87 | US—/3,115 Sec—/203 |
| BPS | $9.01 | US#2,216/3,115 Sec#139/203 |